- Home
- PYPD vs LTRN Comparison
PYPD vs LTRN Comparison
Compare PYPD & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPD
- LTRN
- Stock Information
- Founded
- PYPD 2008
- LTRN 2013
- Country
- PYPD Israel
- LTRN United States
- Employees
- PYPD N/A
- LTRN N/A
- Industry
- PYPD Medical/Dental Instruments
- LTRN Biotechnology: Pharmaceutical Preparations
- Sector
- PYPD Health Care
- LTRN Health Care
- Exchange
- PYPD Nasdaq
- LTRN Nasdaq
- Market Cap
- PYPD 34.8M
- LTRN 36.0M
- IPO Year
- PYPD 2020
- LTRN 2020
- Fundamental
- Price
- PYPD $3.49
- LTRN $4.09
- Analyst Decision
- PYPD Strong Buy
- LTRN Strong Buy
- Analyst Count
- PYPD 5
- LTRN 1
- Target Price
- PYPD $12.00
- LTRN $25.00
- AVG Volume (30 Days)
- PYPD 52.0K
- LTRN 111.9K
- Earning Date
- PYPD 11-12-2025
- LTRN 11-06-2025
- Dividend Yield
- PYPD N/A
- LTRN N/A
- EPS Growth
- PYPD N/A
- LTRN N/A
- EPS
- PYPD N/A
- LTRN N/A
- Revenue
- PYPD N/A
- LTRN N/A
- Revenue This Year
- PYPD N/A
- LTRN N/A
- Revenue Next Year
- PYPD N/A
- LTRN N/A
- P/E Ratio
- PYPD N/A
- LTRN N/A
- Revenue Growth
- PYPD N/A
- LTRN N/A
- 52 Week Low
- PYPD $2.30
- LTRN $2.55
- 52 Week High
- PYPD $3.93
- LTRN $6.12
- Technical
- Relative Strength Index (RSI)
- PYPD 54.23
- LTRN 47.48
- Support Level
- PYPD $3.35
- LTRN $3.85
- Resistance Level
- PYPD $3.54
- LTRN $4.34
- Average True Range (ATR)
- PYPD 0.12
- LTRN 0.30
- MACD
- PYPD 0.00
- LTRN -0.02
- Stochastic Oscillator
- PYPD 75.49
- LTRN 42.42
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.